Clinical discussion highlights combined therapies and on-demand options to smooth out daily motor fluctuations

A recent Neurology Live conversation recording features neurologist Daniel Kremens MD JD and his patient Jo Possenti Jr discussing the real-world complexities of managing daily motor fluctuations. Managing Parkinson's often requires a balancing act when it comes to timing medication. In the early stages, standard treatments keep symptoms under control relatively smoothly. However, as the condition progresses, a challenge known as OFF time frequently emerges. This is the period when standard medications wear off before it is time for the next dose, causing motor symptoms like stiffness, slow movement, or tremors to return. The discussion highlighted how combining targeted therapies can help people reclaim control over these unpredictable fluctuations. One of the most frustrating aspects of OFF time is waking up with it, often called morning akinesia. Because no medication has been taken overnight, the body can feel incredibly rigid and difficult to move first thing in the morning. To address this, neurologists are increasingly turning to on-demand therapies. An injectable option called apomorphine can be used to rapidly rescue someone from an OFF state. Because it bypasses the digestive system entirely, it typically delivers noticeable symptom relief within minutes, helping to restore movement quickly so the day can begin. While rescue therapies are excellent for sudden or expected drops in mobility, long-term management requires smoothing out the day overall. This is where combining medications with different mechanisms becomes essential. For instance, extended-release amantadine works differently from traditional dopamine treatments. It targets NMDA receptors, which are brain signals involved in movement control. By acting on this alternative pathway, it can simultaneously reduce both general OFF time and dyskinesia, the involuntary, jerky movements that sometimes occur when dopamine levels peak. A central takeaway from the panel is that even with well-optimised combinations of long-acting levodopa, on-demand injections, and secondary medications, residual OFF time can still occur unpredictably. The condition changes over time, meaning treatment strategies must remain flexible and highly individualised. For those facing persistent fluctuations despite these combinations, the next step often involves exploring continuous infusion therapies, such as an apomorphine pump, to provide a steady, predictable stream of medication throughout the day. This article details a specific conversation exploring the unique situation and clinical management of one particular patient. It is shared strictly for educational purposes to help broaden general knowledge around treatment options. Because every individual experiences Parkinson's differently, anyone considering adjustments to their personal treatment plan must always consult their own medical team before making any changes.